Ignite Creation Date:
2024-05-19 @ 5:35 PM
Last Modification Date:
2024-10-26 @ 3:29 PM
Study NCT ID:
NCT06412042
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-05-14
First Post:
2024-04-25
Brief Title:
Probiotic in Infant Growth Allergy and Immunity Study
Sponsor:
Wecare Probiotics Co Ltd
Organization:
Wecare Probiotics Co Ltd
Study Overview
Official Title:
Prospective Placebo-Controlled Randomized Double-Blind Clinical Study on the Intervention of Animal-Derived Probiotic in Infant Growth and Development Allergy Incidence and Immune Function
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To evaluate the intervention effects of Bifidobacterium animalis subsp lactis strain BLa80 in promoting growth and development including gut microbiota and physical growth and development of healthy infants and young children across different age groups enhancing immune function improving allergy incidence and analyzing the safety of BLa80 in relation to infant growth and development allergy incidence and gut microbiota
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None